Key Insights TeraGo's estimated fair value is CA$1.16 based on 2 Stage Free Cash Flow to Equity TeraGo's CA$0.97 ...

The premium for the US 10-year Treasury yield continued to fall in August relative to the “fair value” estimate. CapitalSpectator.com’s multi-factor fair-value model has been forecasting for some time ...

In January 2024, InvestingPro’s Fair Value model identified Vaxcyte, Inc. (NASDAQ:PCVX) as significantly overvalued at $60 per share. This analysis proved remarkably accurate, as the stock has since ...

In August 2024, InvestingPro's Fair Value model identified a significant mispricing in (NASDAQ:LZ) shares, highlighting an opportunity that has since delivered impressive returns for investors. The ...

STATEMENT ON AUDITING STANDARDS (SAS) NO. 101, Auditing Fair Value Measurements and Disclosures, gives auditors guidance on understanding how an entity’s management calculates fair value and on ...

When InvestingPro’s Fair Value model flagged Doximity, Inc. (NYSE:DOCS) as significantly overvalued in February 2025, the digital health platform was riding high at $79.23 per share. Fast forward to ...

Analysts have refreshed their view on Veritone, lifting the fair value estimate from US$11.20 to US$12.00, while making only small tweaks to the underlying model inputs. The discount rate has shifted ...

It is highly unlikely that the SEC will tell Congress that "mark-to-market" accounting should be suspended or scrapped when it finishes its 90-day study of the practice, according to industry ...